Ranitidine induces inhibition and structural changes in sucrase.

Abstract

Ranitidine is an antagonist of histamine-2 (H(2)) receptor. It is employed to treat peptic ulcer and other conditions in which gastric acidity must be reduced. Sucrase is a hydrolytic enzyme that catalyzes the breakdown of sucrose to its monomer content. A liquid of yeast sucrase was developed for treatment of congenital sucrase-isomaltase deficiency (CSID… (More)
DOI: 10.3109/14756366.2011.601414

Topics

5 Figures and Tables